Form D · Other Technology

SnapMD, Inc.

Glendale, CA · CIK 0001573226

Offering snapshot reported Sep 27, 2018 · SEC filing

Reported sold
$7.12M
Offering amount: $7.12M
Investors reported
33
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 14, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 27, 2018Initial$7,124,312No comparison33SEC filing
May 4, 2018Initial$1,673,884No comparison26SEC filing
Jun 29, 2017Initial$1,205,686No comparison29SEC filing
Jan 17, 2017Initial$1,750,000No comparison34SEC filing
Jun 30, 2016Initial$1,531,986No comparison34SEC filing
Jan 28, 2016Initial$5,255,595No comparison44SEC filing
Mar 28, 2013Initial$175,000No comparison5SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-322344
Includes $3,832,814 attributable Notes converted to Series B Preferred Stock.

Source: Form D, filed Sep 27, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard P. Boutin Director
Douglas Campbell Director, Executive
Doug Campbell Director, Executive
David T. Lam Director
David Skibinski Director, Executive
George Tierney Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
121 Lexington Drive Suite 412
Glendale, CA, 91203